These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19036912)

  • 21. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating the size and dynamics of an injecting drug user population and implications for health service coverage: comparison of indirect prevalence estimation methods.
    Kimber J; Hickman M; Degenhardt L; Coulson T; van Beek I
    Addiction; 2008 Oct; 103(10):1604-13. PubMed ID: 18638037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.
    Turner KM; Hutchinson S; Vickerman P; Hope V; Craine N; Palmateer N; May M; Taylor A; De Angelis D; Cameron S; Parry J; Lyons M; Goldberg D; Allen E; Hickman M
    Addiction; 2011 Nov; 106(11):1978-88. PubMed ID: 21615585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of hepatitis C virus infection among injecting drug users in Australia.
    Crofts N; Jolley D; Kaldor J; van Beek I; Wodak A
    J Epidemiol Community Health; 1997 Dec; 51(6):692-7. PubMed ID: 9519134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bloodborne viral infection in Irish injecting drug users.
    Smyth BP; Keenan E; O'Connor JJ
    Addiction; 1998 Nov; 93(11):1649-56. PubMed ID: 9926528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
    Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
    Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence and risk behaviours associated with the transmission of blood-borne viruses among ethnic-Vietnamese injecting drug users.
    Hellard ME; Nguyen OK; Guy RJ; Jardine D; Mijch A; Higgs PG
    Aust N Z J Public Health; 2006 Dec; 30(6):519-25. PubMed ID: 17209266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
    Nelson PK; Mathers BM; Cowie B; Hagan H; Des Jarlais D; Horyniak D; Degenhardt L
    Lancet; 2011 Aug; 378(9791):571-83. PubMed ID: 21802134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Burden of Hepatitis C Virus Infection Among Injecting Drug Users: A Mini Systematic Review of Prevalence Studies.
    Rafiq SM; Banik GR; Khan S; Rashid H; Khandaker G
    Infect Disord Drug Targets; 2014; 14(2):93-100. PubMed ID: 25313101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis.
    Harris RJ; Ramsay M; Hope VD; Brant L; Hickman M; Foster GR; De Angelis D
    Eur J Public Health; 2012 Apr; 22(2):187-92. PubMed ID: 21708792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Respondent driven sampling and community structure in a population of injecting drug users, Bristol, UK.
    Mills HL; Colijn C; Vickerman P; Leslie D; Hope V; Hickman M
    Drug Alcohol Depend; 2012 Dec; 126(3):324-32. PubMed ID: 22728045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of injecting drug users in the City of Edinburgh, Scotland, and number infected with human immunodeficiency virus.
    Davies AG; Cormack RM; Richardson AM
    Int J Epidemiol; 1999 Feb; 28(1):117-21. PubMed ID: 10195675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hepatitis C virus epidemic among injecting drug users.
    Pybus OG; Cochrane A; Holmes EC; Simmonds P
    Infect Genet Evol; 2005 Mar; 5(2):131-9. PubMed ID: 15639745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of injecting drug use status on hepatitis C-related referral and treatment.
    Stoové MA; Gifford SM; Dore GJ
    Drug Alcohol Depend; 2005 Jan; 77(1):81-6. PubMed ID: 15607844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic.
    Stimson GV
    Soc Sci Med; 1995 Sep; 41(5):699-716. PubMed ID: 7502102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capture--recapture and anchored prevalence estimation of injecting drug users in England: national and regional estimates.
    Hay G; Gannon M; MacDougall J; Eastwood C; Williams K; Millar T
    Stat Methods Med Res; 2009 Aug; 18(4):323-39. PubMed ID: 19036919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemic of HIV coupled with hepatitis C virus among injecting drug users of Himalayan West Bengal, Eastern India, Bordering Nepal, Bhutan, and Bangladesh.
    Sarkar K; Bal B; Mukherjee R; Chakraborty S; Niyogi SK; Saha MK; Bhattacharya SK
    Subst Use Misuse; 2006; 41(3):341-52. PubMed ID: 16467010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study.
    Sutton AJ; Hope VD; Mathei C; Mravcik V; Sebakova H; Vallejo F; Suligoi B; Brugal MT; Ncube F; Wiessing L; Kretzschmar M
    J Viral Hepat; 2008 Nov; 15(11):809-16. PubMed ID: 18761605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.
    Nasir A; Todd CS; Stanekzai MR; Bautista CT; Botros BA; Scott PT; Strathdee SA; Tjaden J
    Int J Drug Policy; 2011 Mar; 22(2):145-52. PubMed ID: 21146392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.